A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia

NCT05736965 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

AML, Adult

Interventions

DRUG: Selinexor
DRUG: Azacitidine
DRUG: Venetoclax

Sponsor

Shanghai Tong Ren Hospital